BSE: GAYATRIBI · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Gayatri BioOrganics Limited is an Indian manufacturer specialising in the processing of maize into starch and starch derivatives. Its product portfolio includes maize starch, liquid glucose, sorbitol, and gluten, which serve as critical raw materials for the pharmaceutical, food and beverage, textile, and paper industries.
The company operates a large-scale processing facility in Telangana, leveraging proximity to maize-growing regions to optimise supply chain costs. It generates revenue by converting agricultural commodities into value-added industrial chemical products for both domestic and export markets.
Growth is driven by the increasing demand for starch derivatives across diverse industrial sectors and the company's strategic focus on maintaining production capacity in South India. The firm aims to capitalise on its established supply chain to serve expanding domestic and international markets.
Unlock AI insights, financials, peers and live data on Gayatri BioOrganics Ltd and 5,000+ companies — free.
NET PROFIT
₹1 Cr
TTM · standalone
EPS
₹0.09
TTM · standalone
RETURN ON EQUITY
3.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-5.9%
TTM · standalone
P/E
87.8x
Q4 FY26 · standalone
EV/EBITDA
66.6x
Q4 FY26 · standalone
DEBT TO EQUITY
1.0x
Q4 FY26 · standalone
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gayatri BioOrganics LtdGAYATRIBI | ₹61 Cr | 87.78 | 66.62 | — | -59.3% | 3.1% | -5.9% | -33.1% |
POCL EnterprisesPOEL | ₹432 Cr | 11.28 | 8.00 | — | 4.5% | 18.7% | 30.1% | -40.8% |
Blue Pearl Agriventures LimitedBPAGRI | ₹410 Cr | — | — | — | 2.7% | — | — | -93.2% |
Lords Chloro Alkali LimitedLORDSCHLO | ₹394 Cr | 11.41 | 7.79 | 29.8% | 17.3% | 15.6% | 14.1% | -20.6% |
Mangalam OrganicMANORG | ₹392 Cr | 18.31 | 8.38 | 17.3% | 13.6% | 6.8% | 15.9% | -18.6% |
Genus Prime Infra LimitedGENUSPRIME | ₹280 Cr | 7.11 | 36.14 | 543.4% | 181.2% | 4.7% | 4.8% | +15.0% |
As of Q4 FY26
Gayatri BioOrganics Ltd
BSE: GAYATRIBI · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Gayatri BioOrganics Limited is an Indian manufacturer specialising in the processing of maize into starch and starch derivatives. Its product portfolio includes maize starch, liquid glucose, sorbitol, and gluten, which serve as critical raw materials for the pharmaceutical, food and beverage, textile, and paper industries.
The company operates a large-scale processing facility in Telangana, leveraging proximity to maize-growing regions to optimise supply chain costs. It generates revenue by converting agricultural commodities into value-added industrial chemical products for both domestic and export markets.
Growth is driven by the increasing demand for starch derivatives across diverse industrial sectors and the company's strategic focus on maintaining production capacity in South India. The firm aims to capitalise on its established supply chain to serve expanding domestic and international markets.
Unlock AI insights, financials, peers and live data on Gayatri BioOrganics Ltd and 5,000+ companies — free.
NET PROFIT
₹1 Cr
TTM · standalone
EPS
₹0.09
TTM · standalone
RETURN ON EQUITY
3.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-5.9%
TTM · standalone
P/E
87.8x
Q4 FY26 · standalone
EV/EBITDA
66.6x
Q4 FY26 · standalone
DEBT TO EQUITY
1.0x
Q4 FY26 · standalone
As of Q4 FY26